NCT04875039View on ClinicalTrials.gov

Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
AnalgesiaPain, AcuteUpper Extremity Injury
Interventions
DRUG

Dexamethasone

dexamethasone 2 mg will be added to the local anesthetic used to block the cords of the brachial plexus with an infraclavicular approach.

DRUG

Dexmedetomidine-Dexamethasone

A mixture of dexamethasone 2mg with dexmedetomidine 50mcg will be added to the local anesthetic used to block the cords of the brachial plexus with an infraclavicular approach.

Trial Locations (1)

Unknown

Hospital Clínico Universidad de Chile, Santiago

All Listed Sponsors
lead

University of Chile

OTHER

NCT04875039 - Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks | Biotech Hunter | Biotech Hunter